Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 26357.0 | 51 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 22135.0 | 39 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 28206.0 | 37 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 16181.0 | 31 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 10184.0 | 47 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 26540.0 | 80 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | MMP-1 | 29106.5 | 58 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 3985.5 | 40 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 13112.0 | 51 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 390.0 | 37 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 3291.0 | 38 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 6635.0 | 65 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 6890.0 | 43 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 700.5 | 38 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 7599.0 | 48 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 19865.0 | 42 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | MMP-1 | 19066.5 | 48 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 26368.5 | 50 | |
N2759 | TNF-a | 100 | ng/mL | 3 | MMP-1 | 24908.0 | 54 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 8168.0 | 59 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | MMP-1 | 8589.5 | 44 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MMP-1 | 24212.0 | 69 | |
N2586 | TNF-a | 100 | ng/mL | 3 | MMP-1 | 28206.0 | 57 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | MMP-1 | 4009.0 | 45 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | MMP-1 | 4976.0 | 37 |